Jens‐Ulrich Stegmann

Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled study

Craig T. Hartrick, Ilse Van Hove, Jens‐Ulrich Stegmann et al. · Clinical Therapeutics · 2009 · 179 citations

Phase Iii, Osteoarthritis, Orthopaedics +7

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

Stephen Daniels, Ed Casson, Jens‐Ulrich Stegmann et al. · Current Medical Research and Opinion · 2009 · 131 citations

RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes

Ilse Dieussaert, Joon Hyung Kim, Sabine Luik et al. · New England Journal of Medicine · 2024 · 115 citations

The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery

Jens‐Ulrich Stegmann, Horst Weber, Achim Steup et al. · Current Medical Research and Opinion · 2008 · 94 citations

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Yolanda Guerra Mendoza, Elodie Garric, Amanda Leach et al. · Human Vaccines & Immunotherapeutics · 2019 · 65 citations · Full text